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Psychological issues in the treatment of asthmatic
patients
S. CENTANNI*, F. DI MARCO{, F. CASTAGNA*, B. BOVERI{, F. CASANOVA* AND A. PIAZZINI{
*Respiratory Unit, University of Milan, San Paolo Hospital, {Regional Epilepsy Centre, University of Milan,
San Paolo Hospital, and {Institute of Lung Disease, IRCCS Policlinico Hospital,
University of Milan, Italy
Recently published research contends that anxiety and depression are more common in asthmatic patients than in
the general population. Particular psychological profiles could even be a risk factor contributing to deaths caused
by asthma. The purpose of our research was to evaluate the anxiety and depression level in a population of 80
asthmatic patients who were treated in our department, and to judge whether data collected on psychological
profiles of these asthmatic patients can be of any significance when dealing with their pathology. The study
consisted of 40 patients suering from chronic viral hepatitis B or C, and 40 healthy subjects who served as a
control group. Both sets of patients were homogeneous with regard to sex, age and education. All subjects were
tested for anxiety and depression levels with the S.T.A.I. and Zung questionnaires. A structured questionnaire was
employed to assess the daily approach to living with the disease only in asthmatic patients.
The anxiety and depression levels were noticeably higher in asthmatic patients than in patients with chronic liver
disease and healthy subjects. In particular, 34 asthmatic patients scored higher than the S.T.A.I. cut-o (40/80) and
27 attained the same results in the Zung questionnaire. Results from the asthmatic population and healthy subjects
illustrated that women had a higher incidence of anxiety and depression compared to men, although no statistically
significant relationship between sex and questionnaire results was apparent in patients with liver disease. In the year
before assessment, hospitalization and emergency treatment due to asthmatic exacerbation was correlated in
females with a high incidence of anxiety. Additionally, the asthmatic population’s level of education is significantly
related to the incidence of anxiety and depression. With higher education, incidence of depression and anxiety
decreased. This result was not apparent in control groups.
The results of our study were: (1) we confirmed that asthmatic pathology is associated with an increase in
incidence of anxiety and depression, whose presence and seriousness should be taken into consideration in
therapeutic programmes when dealing with a patient; (2) we indicated that a specific approach towards therapy is
crucial when dealing with an asthmatic patient; (3) we suggested how important it is to identify categories of
patients that require more care because of their psychological profile. These findings should provide for the optimal
use of informational resources with important applications for educational programmes and the future treatment of
the asthmatic population.
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The relationship between bronchial asthma and a particular
psychological profile has been studied for years (1–6). In
particular, incidence of anxiety and depression has been
associated with asthmatic pathology. Several studies have
shown a high incidence of well structured psychiatricPaper received 29 March 1999 and accepted in revised form
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0954-6111/00/080742+08 $35?00/0disorders in asthmatic patients, while other authors have
pointed out just a psychological behaviour characterized by
anxious and depressive traits. In conclusion, asthmatics
seem to be distinguished by a psychological profile
described as halfway between patients with anxiety, mood
disorders and the general population (7–9). Many research
studies attempt to explain the relationship between these
two dierent pathologies, which results in an interesting
hypothesis concerning both ventilation control through the
action of central chemoceptors (asthma and anxiety)
(10–12), and diaphragmatic functionality resulting from
bronchial spasms (13,14). For example, it was proved
that hyperventilation induces an onset of panic disorders
in susceptible patients. Such experimental evidence# 2000 HARCOURT PUBLISHERS LTD
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causes panic disorders (15). This hypothesis was disproved,
at least partially, with evidence that inhalation of air
mixtures enriched with 5% CO2 can trigger panic disorders.
Yellowlees (16–19) emphasized the similarities between
asthmatic and anxious patients. In fact, both exhibit
defensive behaviour: the former avoids conditions that
may cause bronchial spasms, the latter avoids anxiety-
inducing circumstances. A repressive coping style appears
to be a risk factor for asthma morbidity because it is
accompanied by an impaired ability to perceive symptoms,
a necessary prerequisite for taking appropriate remediation
(20). Isenberg et al. have shown that defensiveness may
increase risk of asthma morbidity, due to inaccuracy in
detecting sensation of dyspnoea during asthma exacerba-
tions; the authors supposed that the inaccuracy may be
caused by elevated endogenous opioids among defensive
individuals (21). The purpose of our research is to evaluate
the anxiety and depression level in a population of 80
asthmatic patients, and to judge whether data collected on
psychological profiles of these asthmatic patients can be of
any significance when dealing with their pathology.
Materials and methods
We enrolled 160 subjects: 80 consecutive asthmatic patients
were monitored by our Respiratory Unit, 40 of whom
suered from chronic viral hepatitis B or C and were
monitored by Hepatology outpatients’ department of the
San Paolo Hospital (Milan), and the remaining 40 were
healthy subjects.
Bronchial asthma has been diagnosed according to
International Guidelines (22,23), which require contem-
poraneous presence of clinical (dyspnoea, cough and
wheezing) and instrumental conditions typical of the
pathology. The distribution between the sexes, in our
sample, with about 65% being women, is parallel to
previous studies carried out on a very large scale in adult
asthmatic patients (24), and confirms the representativity of
our 80 consecutive enrolled asthmatic patients. All patients
were positive to bronchial provocation challenge with
methacholine [decrease in forced expiratory volume in
1 sec (FEV1) of 20% or more] (25), delivered by MB3
MEFAR1 dosimeter. The observed PD20 FEV1 was
375+25mg (mean+SE). In our experiment, 58% of patients
suered from allergic asthma (positive skin test to one or
more allergens) and basal FEV1 resulted 754%+12
(mean+SE) compared to the predicted value. Using the
international guidelines (26), the severity of disease (inter-
mittent, mild, moderate and severe) was evaluated by the
pneumologist on the basis of symptoms, especially night
awakening due to asthma, PEF stability in the month
before enlistment and basal FEV1. Patients with chronic
liver disease and healthy subjects were recruited as control
groups and, therefore, stratified according to sex, age and
education to parallel the asthmatic sample. Patients with
chronic liver disease underwent periodic clinical and
laboratory tests, thus requiring their full co-operation and
participation. It is important to note that all patients withchronic viral hepatitis follow sanitary-hygienic precautions
in order to reduce any risk of transmitting the infection to
family members or co-inhabitants through the exchange of
bodily fluids; therefore alimentary, social and sexual habits
of patients are always conditioned by the disease. Patients
with liver disease being treated with interferon were excluded
because of the negative eect of the drug on mood (27).
The selection of healthy subjects took into consideration
clinical case-history, clinical examination and spirometry in
basal condition. After collecting data, a further analysis
was carried out on the distribution of variables characteriz-
ing both groups in order to verify that they were
comparable. The exception was disease duration, which
was found to be significantly higher among asthmatic
rather than patients with liver disease. This result was
attributed to the peculiar epidemiology of both pathologies.
Characteristics of the three samples are reported in
Table 1. Questionnaires were independently completed.
Exclusion criteria valid for all three samples were:
diagnosis of any psychiatric pathology and psychotropic
drug taking.
Asthmatic patients were requested to fill in three
questionnaires.
S.T.A.I. QUESTIONNAIRE (28)
S.T.A.I. (State Trait Anxiety Inventory) contains 20 items
equally divided between positive and negative statements
regarding anxiety. For example, statements such as: ‘I feel
under pressure’ and ‘I feel self-confident’ are found in the
questionnaire. There is a random distribution of statements
which is aimed at preventing patients from being acquies-
cent and standardizing their answers. Patients are requested
to comment on each statement as follows: ‘(not) at all’, ‘a
little’, ‘fairly’ or ‘very much’. They have to mark the answer
that best suits their present state of mind without providing
a detailed answer. The subjects were informed that no right
or wrong answers existed. The S.T.A.I. questionnaire was
used to evaluate traits of anxiety among healthy, grown-up
subjects and among psychiatric patients suering from both
medical and surgical pathologies. The main variables that
the questionnaire measures are anxiety, apprehension,
nervousness, tension and concern. The evaluation is simple:
each answer is given a score of 1 to 4 points. A high score is
associated with higher anxiety level. The questionnaire’s
cut-o is 40 points out of 80. Studies carried out on patients
with anxiety disorders confirmed the questionnaire’s
reliability in accurately measuring anxiety levels (29,30).
ZUNG QUESTIONNAIRE (31–33)
Some of the ZUNG questionarie’s characteristics overlap
S.T.A.I., since it also contains 20 items with negative and
positive contents. This questionnaire evaluates depression
level. Some of the comments or statements included in
the questionnaire are as follows: ‘seldom’, ‘sometimes’,
‘often’ or ‘almost always’, which point out how often
some conditions occur. Patients are given the same
instructions as in the S.T.A.I. questionnaire, and also in
TABLE 1. Base-line characteristics of the study patients*
Asthmatic patients Patients with chronic
liver disease
Healthy
subjects
No. of subjects 80 40 40
Male/female 27/53 14/26 14/26
Age (years) 397+164 422+16 416+16
No of smoker patients (%) 20 (25) 10 (25) 11 (275)
Total cigarette smoking (pack-years) 149+18 235+44 192+22
School attendance (years) 114+04 101+06 111+06
Pathology duration (months){ 1271+137 525+77 —
S.T.A.I. score 402+12{ 355+11 353+09
Zung score 366+09{ 330+10 319+09
FEV1(%) / PD20 FEV1 (mg) 754+12 / 375+25 — —
*Plus-minus values are mean+SE;
{P5001;
{P5005
744 S. CENTANNI ET AL.this case, each answer is given 1 to 4 points. A high score
indicates higher traits of depression. The cut-o is 40 out of
80. In 1990, a study carried out by the same author
demonstrated that using the criteria of DSM-III as a
standard, the questionnaire has 97% sensitivity and 63%
specificity (34).
SELF-ADMINISTERED, STRUCTURED
QUESTIONNAIRE (35)
This questionaire is based on an ordinal and nominal scale,
with 17 items, five of which concern personal data. It was
originally drafted by the Regional Epilepsy Centre of the S.
Paolo Hospital, and is currently about to be validated and
standardized. It was adapted to asthmatic patients and
contains questions on emotional and behavioural modal-
ities relating to: disease, the role that pharmacological
therapy plays in patients’ perception, the eect that
pathology has on daily life and especially on interpersonal
relationships.
Patients with liver disease and healthy subjects were
requested to answer only S.T.A.I. and ZUNG question-
naires.
STATISTICAL ANALYSIS
We analysed the data using the Statistical Package for the
Social Science for Windows (version 7.0, SPSS, Chicago,
U.S.A.). Descriptive data for continuous variables are
presented as means+SE. The base-line characteristics of the
patients in the three groups were compared by means of
analysis of variance for continuous variables and the w2-test
for categorical variables (36). The data were analysed with
repeated-measured analyses of variance, paired t-test,
w2-test, Pearson’s correlation test and linear regression.
All statistical test were two-sided. The significance was set
at P5005.Results
The initial data emerging from this research shows that
asthmatic patients scored significantly higher than controls
both in ZUNG and S.T.A.I. questionnaires (Table 1).
There is no significant variation between patients with liver
disease and healthy subjects, despite the former showing
higher traits of anxiety and depression. The cut-o in both
questionnaires is a score of 40 out of 80. For the S.T.A.I.
questionnaire, 34 asthmatic patients, 10 patients with liver
disease and eight healthy subjects scored higher than the
cut-o point. In the ZUNG questionnaire, 27 asthmatic
patients, 10 patients with liver disease and five healthy
subjects surpassed the cut-o level.
In the asthmatic and healthy populations, females had
higher scores in both questionnaires, whereas among
patients with liver disease, the two subgroups showed no
dierence (Table 2). There were no significant dierences
between male and female asthmatics with regard to age,
type of asthma, disease duration and education (Table 3).
However, women were more numerous in the asthmatic
hospitalized subgroup and among those admitted to an
emergency room. One woman out of five has been
hospitalized or admitted to an emergency room compared
to one man out of 27. The percentage of patients who
reported themselves as not complying consistently with
their therapy was significantly higher among men suering
from bronchial asthma (40%) than among women (17 %)
(Table 3). A subgroup consisting of 12 patients (11 female
and one male) who were hospitalized at least once was
compared with a group which had no emergency treatment
(Table 4). The S.T.A.I. questionnaire score was significantly
higher among the former, but the ZUNG score dierence
did not reach statistical significance.
The relationship between the age of the subjects and the
duration of the disease was evaluated for S.T.A.I. and
ZUNG questionnaire scores. A significant correlation
between age and the S.T.A.I. questionnaire score
TABLE 2. S.T.A.I. and Zung: dierent scores between males and females*
Asthmatic
Patients{
Patients with chronic
liver disease
Healthy subjects{
S.T.A.I. score Female 420+14 358+14 368+12
Male 367+14 372+14 326+12
Zung score Female 385+11 331+13 341+12
Male 329+10 335+18 277+09
*Plus-minus values are mean+SE;
{P5005;
{P5001.
TABLE 3. Characteristics of male and female in the asthmatic group*
Asthmatic patients Male
(27 patients)
Female
(53 patients)
Age (years) 378+29 400+20
No of patients in need of
urgent hospital care (%){
1 (4) 11 (21)
School attendance (years) 112+07 115+05
Pathology duration (months) 1325+233 1244+170
No. of patients with a low
compliance to the therapy (%){
11 (40) 9 (17)
FEV1 (%) 767+14 747+11
*Plus-minus values are mean+SE;
{P5005.
TABLE 4. Asthmatic patients in need of urgent hospital care:
S.T.A.I. and Zung scores*
S.T.A.I. score Zung score
Hospital & Emergency Room
Yes (12 patients) 490+38{ 400+25
No (68 patients) 386+11{ 361+09
Asthma severity
Intermittent 395+29 355+17
Mild 375+13 365+17
Moderate 412+18 372+15
Severe 455+44 378+31
*Plus-minus values are mean+SE;
{P5001.
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indicate that scores are higher as age increases. In patients
with liver disease, scores in the same questionnaire were
significantly higher among those with a more recent
pathology (P5005). Moreover, the ZUNG questionnairescores also evidenced a direct correlation to the age of
patients with liver disease (P5005), and suggested a
tendency towards higher incidence of depression among
elder patients. Age seems to have no aect on incidence of
anxiety and depression among healthy subjects.
The relationship between the varying grade levels of
asthma (30) and the following variables were evaluated:
education, sex, compliance with therapy, and S.T.A.I. and
ZUNG scores; these last-mentioned show an increased
trend along with the worsening of asthma severity (except
for the relationship between S.T.A.I. score and intermittent
asthma), even if this trend did not reach any statistical
significance (Table 4).
The level of education among subjects was studied in
depth. Patients of all three groups were divided into three
subgroups: school attendance for less than 8 years, between
9 and 13 years, for longer than 13 years. In asthmatic
patients the S.T.A.I. scores were: 428+23, 399+14
and 328+08; and the ZUNG scores were: 429+23,
366+12 and 301+16. So, score results are lower in
both questionnaires among asthmatic patients as educa-
tion levels rise (P5005), while that was not the case
in the group of patients with liver disease and healthy
subjects.
TABLE 5. Self-administred structured questionnaire for asthmatic patients*
n8 Questions-Answers N8 M/F LS/HS LZ/HZ
1. Do you think asthma can be treated with:
Appropriate drugs 74 24/50 43/31 49/25
Surgery or psychotherapy 0 — — —
Particular life-style 4 2/2 2/2 2/2
Alternative therapies (homeopathy etc) 1 1/0 1/0 1/0
It disappears spontaneously 1 0/1 0/1 1/0
No 0 — — —
2. To recover from asthma means:
Having no more attacks but continuing to take drugs 28 7/21 18/10 16/12
Having very mild attacks imperceptible to others 2 0/2 0/2 1/1
Having normal, unprejudiced social relationships 1 0/1 0/1 0/1
Withdrawing any drugs 49 20/29 28/21 36/13
3. What bothers you most about the regular assumption of
drugs for asthma?
Possible side eects 42 14/28 27/15 30/12
An inferior complex 4 0/4 2/2 2/2
The fact that every time you take drugs you are reminded of the
disease
34 13/21 17/17 21/13
4. Why do you think you have to take drugs?
They control bronchial hyperreactivity 27 12/15 16/11 19/18
They help to improve dyspnoea 23 7/16 16/7 17/6
They help you to feel well 30 8/22 14/16 17/13
5. Somebody suering from asthma can more easily accept
taking drugs for a long period if:
He/she is told immediately at the initial diagnosis 25 11/14 16/9 17/8
The doctor monitors him/her constantly 21 5/16 11/10 13/8
He/she does not have any side eects 34 11/23 19/15 23/11
6. What do your partner or your close relatives think about
your following this therapy for a long time?
That I will never recover completely 3 1/2 3/0 2/1
That I will become dependent on drugs 3 2/1 2/1 1/2
That what really counts is the fact of not having attacks any more 74 24/50 41/33 50/24
7. Taking drugs means:
That your life depends on a external factor 8 2/6 5/3 6/2
Being inferior to others who do not take any drugs 0 — — —
Controlling attacks and leading a normal life 72 25/47 41/31 47/25
8. What scares me most is:
Knowing that I am not able to control my body completely 37 12/25 23/14 25/12
Knowing that I depend on drugs 21 10/21 15/16 20/11
Knowing that I am considered to be sick 5 3/2 2/3 2/3
Something else (specify) 7 2/5 6/1 6/1
9. Asthma, compared to other diseases, is:
Worse because it can restrict some activities 16 7/9 7/9 10/6
Worse because it is dicult to keep under control 6 2/4 3/3 4/2
A disease like any other 58 18/40 36/22 39/19
10. Having no attacks, going on with the drugs, means for me:
An unsuccessful result 9 4/5 6/3 5/4
That my asthma is particularly severe 17 8/9 8/9 10/7
A normal result 54 15/39 32/22 38/16
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TABLE 5. Self-administred structured questionnaire for asthmatic patients*
n8 Questions-Answers N8 M/F LS/HS LZ/HZ
11. Has asthma entailed changes/restrictions in your life?
Yes 29 9/20 14/15 14/15{
No 51 18/33 29/22 39/12
12. If asthma has changed your life, in which area:
School-Employment 15 5/10 7/8 8/7
Free time (holidays, sport, hobbies, etc) 5 1/4 2/3 2/3
Familiar and social life 1 1/0 0/1 0/1
Life-style 1 0/1 0/1 1/0
Something else 7 2/5 5/2 3/4
*Plus-minus values are mean+SE;
{P5005;
M/F: male/female;
HS/LS: high score in S.T.A.I. questionnaire (440/80)/low score (540/80);
HZ/LZ: high score in Zung questionnaire (440/80)/low score (540/80).
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women claim to follow therapy programmes more rigor-
ously than men (Table 3), and patients with higher anxiety
and depression levels claim to follow therapy more regularly.
As mentioned above, the third stage in data collection
focused on the questionnaire exclusively tailored for
asthmatic patients (Table 5). It refers to the patient’s
personal experience with the disease, and especially his or
her attitude towards therapy and recovery. We did not find
any association between any single answer (e.g. ‘Having no
attack, going on with the drugs, means for me an
unsuccessful result’) and a particular subgroup character-
ized by the variable: sex, age, pathology duration, asthma
severity, STAI and ZUNG score, education level and
admittance to emergency room (e.g. young women suered
from severe asthma). The only significant connection was
detected between a score higher than 40/80 in the ZUNG
questionnaire (high depression level) and the answer ‘yes’ to
the question: ‘Has asthma entailed changes/restrictions in
your life?’ (P5005).
Discussion
Our research demonstrates that anxiety and depression are
more apparent among asthmatic patients than patients with
liver disease and healthy subjects. On one hand, our data
confirm the results of some existing research, and on the
other hand, they render new conclusions, since patients
with an asymptomatic, chronic pathology were used in the
control population. As patients with chronic liver disease
are asymptomatic they are not a suitable control group to
evaluate the psychological impact caused by the symptoms
of the disease on anxiety and depression levels, but
nonetheless they exemplify a satisfactory conscious past in
illness experience. Periodical clinical examinations, restric-
tion in life-style and fear of a possible worsening of thedisease, which are all characteristics of the enlisted patients
with chronic liver disease, however, have an influence on
their daily approach to living with the disease.
Asthmatic women have higher levels of anxiety and
depression than men, and they seek medical assistance in
hospital facilities more frequently. A recent paper from
Innes et al. (37) shows how women are more at risk of
serious asthma attack and even fatal asthma. Besides
gender, another important risk factor correlated with
admission to emergency rooms is a high anxiety level. In
fact other published data point out that very severe asthma
attacks are associated with a depressive psychological
profile, especially denial. In this regard, Allen et al. (14)
studying an asthmatic population, demonstrated that
asthmatic patients with a depressive psychological profile
show a risk of impaired maximal voluntary activation of
the diaphragm that is 3.5 times greater than in non-
depressed asthmatics. This result seem in contrast with our
findings, but this is probably because 12 of our patients
suered a simple exacerbation of their disease and not a
nearly fatal attack; this means that there is a great clinical
dierence between the two events. Our study indicates that
in an asthmatic group but not among patients with liver
disease and healthy subjects, education levels are inversely
related to anxiety and depression. Patients with a higher
level of education scored lower in S.T.A.I. and ZUNG
questionnaires; this fact stresses the relevance, in the case of
bronchial asthma, of a correct understanding on the part of
the patients of the dierent aspects of the disease, which is
however less important for a chronic and complex disease
like viral hepatitis. The trend regarding the relationship
between asthma severity and S.T.A.I. and ZUNG scores
matches the one found by Silverglade et al. (38) in 1994,
although these authors had selected adolescent patients
divided in only three levels of asthma severity.
It was determined that 65% of patients identify recovery
with independence from medication and not with clinical
748 S. CENTANNI ET AL.well being. The remaining 35% have the opposite point of
view. Almost 1/4 asthmatic patients, especially men, admit
to not taking their therapy regularly. It is very important to
emphasize how asthmatics, because of characteristics
intrinsic to their disease, have to keep taking their
prescribed therapies even when they do not suer from
any symptoms. Our data show that low depression and
anxiety levels are associated with a low compliance with
pharmacological therapy. Anyway, it is worth nothing that
Bosley et al. (39) showed in 1995 that patients’ self-report
and compliance assessed by computerized device are poorly
correlated.
Bronchial asthma does not have any particular stigma
associated with it. In most cases, this pathology is
considered to be neither better nor worse than others, and
does not interfere with interpersonal relationships. Sex, age,
compliance with therapy and type of asthma do not modify
the patient’s emotional relation to and experience of their
disease. Yet it is important to point out that patients with a
greater predisposition to incidence of depression report a
greater awareness of their limitations, thus aecting their
private and social life, and leisure activities.
In our opinion, the time and resource investment
employed in gathering these data, although minimum,
seems to be an eective as well as ecient way of
proceeding, which could be beneficial for a better fitted
treatment of asthmatic patients in the future.
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